Tarsus Pharmaceuticals TARS
NASDAQ TARS
$75.81 +1.98 (+2.68%)
As of: Nov 11, 2026 · 11:47 AM EST

Tarsus Pharmaceuticals (TARS) Net Equity Issued and Repurchased (2019 - 2026)

Updated

Tarsus Pharmaceuticals (TARS) reported Net Equity Issued and Repurchased of $127.81 million for Q3 2026, compared with $2.56 million a year earlier.

Analysis

Tarsus Pharmaceuticals (TARS) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Tarsus Pharmaceuticals' Net Equity Issued and Repurchased came in at -$144,000; for FY2025, it was $8.62 million, down 48.6% from FY2024.

  • Net Equity Issued and Repurchased has a five-year compound annual growth rate of -42.0% (FY2020 to FY2025).
  • By year, Net Equity Issued and Repurchased came in at $16.77 million in FY2024 (+963.3%), $1.58 million in FY2023 (+169.6%), $585,000 in FY2022 (+80.6%) and $324,000 in FY2021 (-99.8%).
  • The Q3 2026 figure ranks as the highest quarterly Net Equity Issued and Repurchased since Q1 2025.
  • Year over year, Net Equity Issued and Repurchased gained in three of the last five quarters, with growth averaging 49.3%.
  • The high point for year-over-year Net Equity Issued and Repurchased in five years was Q2 2024 (growth of 425.5%); the low point was Q4 2021 (a decline of 99.7%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $3.3 million (Q2 2026), $1.2 million (Q1 2026) and -$132.46 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Tarsus Pharmaceuticals 3.64 Bn 2.07 Bn 180.68 Mn 127.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 127.81 Mn
Jun 30, 2026 3.30 Mn
Mar 31, 2026 1.20 Mn
Dec 31, 2025 -132.46 Mn
Sep 30, 2025 2.56 Mn
Jun 30, 2025 1.95 Mn
Mar 31, 2025 136.56 Mn
Dec 31, 2024 -95.36 Mn
Sep 30, 2024 678,000.00
Jun 30, 2024 2.68 Mn
Mar 31, 2024 108.77 Mn
Dec 31, 2023 -98.84 Mn
Sep 30, 2023 99.89 Mn
Jun 30, 2023 510,000.00
Mar 31, 2023 13,000.00
Dec 31, 2022 -74.09 Mn
Sep 30, 2022 -136,000.00
Jun 30, 2022 74.81 Mn
Dec 31, 2021 229,000.00
Sep 30, 2021 75,000.00
API Access

Tarsus Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TARS&period=max&api_key=YOUR_API_KEY